J&J Bit Off More Than McNeil Could Chew In 2006 Pfizer OTC Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
McNeil scaled up its manufacturing “volume and complexity substantially” following J&J’s acquisition of Pfizer’s consumer business in 2006, says McNeil Consumer VP Shane Freedman. “Just a few years later, we had the recalls” that led eventually to a consent decree with FDA,” he says.